Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 676 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Teva UK unveils generic Tolterodine capsules

Tolterodine is a generic version of Detrusitol (tolterodine) while Tolterodine XL (Mariosea XL) is a generic version of Detrusitol XL (tolterodine XL) from Pfizer, both indicated for the

Julphar opens new insulin plant in UAE

The new plant will manufacture and distribute insulin, a diabetes product. The plant is expected to produce nearly 1,500kg/y of insulin or around 45m vials. Julphar also said

FDA delays decision on SalixPharma diarrhea drug

Crofelemer is designed to provide symptomatic relief of non-infectious diarrhea in patients with HIV/AIDS on anti-retroviral therapy. Salix chief development officer and medical, research and development executive vice

Mylan settles Detrol LA patent litigation

The litigation is related to Mylan Pharmaceuticals’ abbreviated new drug application (ANDA) for Tolterodine Tartrate ER capsules, 2mg and 4mg, the generic version of Pfizer’s Detrol LA, indicated

Meda to take over Jazz women’s health business

The women’s health business includes six products Elestrin (estradiol gel), Gastrocrom (cromolyn sodium, USP), Natelle One (prenatal vitamin), AVC Cream (sulfanilamide), Gesticare DHA (prenatal multi-vitamin) and Urelle (urinary

FGSCDA develops new drug information software

The software, which contains data on approximately 50,000 brands and their properties, will provide the information and components of the product along with its ingredients, strength, approximate price,

SFJ, Pfizer partner to co-develop lung cancer drug

The collaboration will focus on conducting Phase 3 clinical trial of Pfizer’s investigational pan-human epidermal growth factor receptor (pan-HER) inhibitor, dacomitinib (PF-00299804), which will be conducted across multiple